| [1] |
Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management [J]. Nurs Stand, 2022, 37(1): 61-66.
|
| [2] |
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 [J]. Diabetes Res Clin Pract, 2022, 183: 109119.
|
| [3] |
Ma X, Liu R, Xi X, et al. Global burden of chronic kidney disease due to diabetes mellitus, 1990-2021, and projections to 2050 [J]. Front Endocrinol (Lausanne), 2025, 16: 1513008.
|
| [4] |
Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update [J]. Med Clin North Am, 2023, 107(4): 689-705.
|
| [5] |
Młynarska E, Buławska D, Czarnik W, et al. Novel insights into diabetic kidney disease [J]. Int J Mol Sci, 2024, 25(18): 10222.
|
| [6] |
Graterol TF, Molina M, Soler-majoral J, et al. Evolving concepts on inflammatory biomarkers and malnutrition in chronic kidney disease [J]. Nutrients, 2022, 14(20): 4297.
|
| [7] |
Park J, Kim HJ, Kim J, et al. Predictive value of serum albumin-to-globulin ratio for incident chronic kidney disease: a 12-year community-based prospective study [J]. PLoS One, 2020, 15(9): e0238421.
|
| [8] |
Xi W, Wu C, Liang Y, et al. Analysis of malnutrition factors for inpatients with chronic kidney disease [J]. Front Nutr, 2022, 9: 1002498.
|
| [9] |
Cheng L, Li L, Liu C, et al. Prealbumin correlates with C-reactive protein in rheumatic musculoskeletal diseases [J]. Ann Clin Lab Sci, 2021, 51(1): 82-89.
|
| [10] |
孙胜杰,姚丽娣,刘东,等. DCE-MRI参数评估喉癌术后放疗短期预后的研究[J]. 陆军军医大学学报,2025, 47(12): 1358-1366.
|
| [11] |
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020 [J]. Diabetes Care, 2020, 43(Suppl 1): S14-S31.
|
| [12] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease [J]. Kidney Int, 2024, 105(4S): S117-S314.
|
| [13] |
上海市肾内科临床质量控制中心专家组. 慢性肾脏病早期筛查、诊断及防治指南(2022年版)[J]. 中华肾脏病杂志,2022, 38(5): 453-464.
|
| [14] |
Sciatti E, Ceconi C. Diabetes mellitus and chronic kidney disease: a neglected and dangerous liaison [J]. Eur J Prev Cardiol, 2020, 27(18): 1920-1921.
|
| [15] |
Shubrook JH, Neumiller JJ, Wright E. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations [J]. Postgrad Med, 2022, 134(4): 376-387.
|
| [16] |
Vijay K, Neuen BL, Lerma EV. Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities [J]. Cardiorenal Med, 2022, 12(1): 1-10.
|
| [17] |
Sun L, Li C, Feng B, et al. The associations between albumin, globulin, albumin-to-globulin ratio, and frailty in middle-aged and older adults: evidence from NHANES 2013-2014 [J]. Curr Pharm Des, 2025, 31(41): 3303-3311.
|
| [18] |
Zeng M, Liu Y, Liu F, et al. Association between albumin-to-globulin ratio and long-term mortality in patients with chronic kidney disease: a cohort study [J]. Int Urol Nephrol, 2020, 52(6): 1103-1115.
|
| [19] |
Burlaka IA, Mityuryayeva IO, Shevchenko TA, et al. Clinical, laboratory, instrumental, anamnestic characteristics in children with type i diabetes mellitus and early stage of diabetic nephropathy [J]. Glob Pediatr Health, 2021, 8: 2333794X211063052.
|
| [20] |
Nichols GA, Déruaz-luyet A, Brodovicz KG, et al. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes [J]. BMC Nephrol, 2020, 21(1): 167.
|
| [21] |
Stenvinkel P, Chertow GM, Devarajan P, et al. Chronic inflammation in chronic kidney disease progression: role of Nrf2 [J]. Kidney Int Rep, 2021, 6(7): 1775-1787.
|
| [22] |
Ahn SS, Yoon T, Song JJ, et al. Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: a prospective cohort study [J]. PLoS One, 2022, 17(7): e0271055.
|
| [23] |
Barril G, Nogueira A, Alvarez-García G, et al. Nutritional predictors of mortality after 10 years of follow-up in patients with chronic kidney disease at a multidisciplinary unit of advanced chronic kidney disease [J]. Nutrients, 2022, 14(18): 3848.
|
| [24] |
Fujii M, Ohno Y, Ikeda A, et al. Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the national database of health checkups in Japan [J]. Hypertens Res, 2023, 46(5): 1075-1089.
|
| [25] |
Zhang R, Jiao Y, Wu Y, et al. Serum globulin and albumin-to-globulin ratio are associated with diabetic kidney disease but not diabetic retinopathy in type 2 diabetes mellitus patients: a cross-sectional study [J]. J Inflamm Res, 2024, 17: 11545-11559.
|
| [26] |
Zhou X, Ruan W, Zhao L, et al. Causal links between renal function and cardiac structure, function, and disease risk [J]. Glob Heart, 2024, 19(1): 83.
|
| [27] |
Zhang B, Dai C, Jiang J, et al. Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry [J]. Diabetol Metab Syndr, 2025, 17(1): 197.
|
| [28] |
Longhitano E, Calabrese V, Casuscelli C, et al. Proteinuria and progression of renal damage: the main pathogenetic mechanisms and pharmacological approach [J]. Medicina (Kaunas), 2024, 60(11): 1821.
|